Shopping Cart
Remove All
Your shopping cart is currently empty
Akt1&PKA-IN-2 ((R)-29), a compound specific to PKB/AKT and selective for cyclin-dependent kinase 2 (CDK2), effectively inhibits AKT1, PKAa, and CDK2a with IC50 values of 0.007 µM, 0.01 µM, and 0.69 µM, respectively.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,140 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,490 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,390 | 6-8 weeks | 6-8 weeks |
| Description | Akt1&PKA-IN-2 ((R)-29), a compound specific to PKB/AKT and selective for cyclin-dependent kinase 2 (CDK2), effectively inhibits AKT1, PKAa, and CDK2a with IC50 values of 0.007 µM, 0.01 µM, and 0.69 µM, respectively. |
| Targets&IC50 | Akt1:0.007 μM, CDK2A:0.69 μM |
| Molecular Weight | 386.27 |
| Formula | C20H17Cl2N3O |
| Cas No. | 1334108-00-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.